We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$778M
AUM Growth
+$41.1M
Cap. Flow
-$3.71M
Cap. Flow %
-0.48%
Top 10 Hldgs %
60.4%
Holding
78
New
1
Increased
28
Reduced
40
Closed
2

Top Buys

Rank Stock Value
1
CASY icon
Casey's General Stores
CASY
+$2.7M
2
PAYC icon
Paycom
PAYC
+$1.51M
3
DHR icon
Danaher
DHR
+$1.31M
4
LLY icon
Eli Lilly
LLY
+$1.3M
5
PANW icon
Palo Alto Networks
PANW
+$1.18M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.78M
2
NVDA icon
NVIDIA
NVDA
+$4.56M
3
AAPL icon
Apple
AAPL
+$1.7M
4
PEP icon
PepsiCo
PEP
+$1.55M
5
ADBE icon
Adobe
ADBE
+$557K

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Healthcare 15.24%
3 Consumer Discretionary 13.12%
4 Communication Services 9.2%
5 Financials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
76
ImmunityBio
IBRX
$7.8B
$52K 0.01%
25,800
CMCSA icon
77
Comcast
CMCSA
$84B
-5,728
Closed -$206K
PYPL icon
78
PayPal
PYPL
$49.3B
-3,398
Closed -$251K

Similar funds

Dillon & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Dillon & Associates held 78 positions worth $778M, up 5.6% from $737M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 3.8%. Dillon & Associates opened 1 new position and exited 2, leaving the 78-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q3 2025 buy was Palantir: 1,305 shares worth $238K.
  • Dillon & Associates added most to Casey's General Stores in Q3 2025, an estimated $2.7M increase.
  • Dillon & Associates's biggest Q3 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $4.78M.
  • Dillon & Associates fully exited PayPal in Q3 2025, selling an estimated $251K.
  • Dillon & Associates's ten largest holdings make up 60% of its $778M portfolio in Q3 2025.
  • Dillon & Associates opened 1 new position and closed 2 in Q3 2025.
  • Dillon & Associates's portfolio value rose 5.6% quarter-over-quarter to $778M.

Based on Dillon & Associates's 13F filing for Q3 2025, filed 28 Oct 2025.